rethinkPeptides Search
Menu
Study breakdown

Cell-Penetrating Peptides as Viral Gene Therapy Delivery Enhancers

evidence
The takeaway

Pro-rich and octaarginine cell-penetrating peptides enhanced adenovirus vector cellular uptake, improving gene therapy delivery efficiency — peptides as tools to boost viral gene therapy.

Key finding

Pro-rich and octaarginine cell-penetrating peptides enhanced adenovirus vector cellular uptake, improving gene therapy delivery efficiency — peptides

What the researchers found

Pro-rich and octaarginine cell-penetrating peptides enhanced adenovirus vector cellular uptake, improving gene therapy delivery efficiency — peptides as tools to boost viral gene therapy.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Cell-Penetrating Peptides as Viral Gene Therapy Delivery Enhancers
What was found?
Pro-rich and octaarginine cell-penetrating peptides enhanced adenovirus vector cellular uptake, improving gene therapy delivery efficiency — peptides as tools to boost viral gene therapy.

Read the original research

Evaluation of synthetic cell-penetrating peptides, Pro-rich peptide and octaargine derivatives, as adenovirus vector carrier.

Protein and peptide letters, 17(2), 164-7

Citation

Kida, Shinya; Eto, Yusuke; Yoshioka, Yasuo; Nakagawa, Shinsaku; Kawasaki, Koichi; Maeda, Mitsuko. (2010). Evaluation of synthetic cell-penetrating peptides, Pro-rich peptide and octaargine derivatives, as adenovirus vector carrier.. Protein and peptide letters, 17(2), 164-7.